{"id":"NCT01575561","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296","officialTitle":"A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06","primaryCompletion":"2015-07","completion":"2015-07","firstPosted":"2012-04-11","resultsPosted":"2016-08-22","lastUpdate":"2016-08-22"},"enrollment":377,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar I Disorder"],"interventions":[{"type":"DRUG","name":"Lurasidone","otherNames":[]}],"arms":[{"label":"Lurasidone","type":"EXPERIMENTAL"}],"summary":"This is an open-label, multi-center,12 week extension study designed to evaluate the longer term safety, tolerability and effectiveness of lurasidone, flexibly dosed, adjunctive to lithium or divalproex for the treatment of subjects with bipolar I disorder, who have either completed the core study D1050296 or experienced a protocol defined recurrence of a mood event in the double-blind phase of the core study D1050296","primaryOutcome":{"measure":"Treatment-emergent Adverse Events and Treatment-emergent Adverse Events Leading to Discontinuation and Serious Adverse Events","timeFrame":"12 weeks","effectByArm":[{"arm":"Lurasidone","deltaMin":155,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":2},"locations":{"siteCount":71,"countries":["United States","Argentina","Bulgaria","Chile","Czechia","France","Hungary","Japan","Poland","Russia","Serbia","Slovakia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":377},"commonTop":["headache","nasopharyngitis","akathisia","insomnia","nausea"]}}